Status:
UNKNOWN
Prevalence of Macrovascular Disease in Type 2 Diabetes Mellitus
Lead Sponsor:
Odense University Hospital
Conditions:
Type 2 Diabetes Mellitus
Eligibility:
All Genders
20+ years
Brief Summary
The study aim is to establish a consecutive population of newly referred type 2 diabetes mellitus patients and among these to describe the degree of macrovascular disease by evaluating left ventricula...
Eligibility Criteria
Inclusion
- Age: ≥ 20 years.
- Fasting C-peptide \> 300 pmol/l.
Exclusion
- Verified medical history of macrovascular disease (stroke, myocardiac infarct, coronary revascularisation or strain gauge toe blood pressure \< 30 mmHg).
- Suspected short lifespan because of malignant disease or end-stage kidney disease.
- Pregnancy or planned pregnancy during the study period.
- Body weight \> 150 kg.
- Physical or mental disability not enabling participation in the study.
Key Trial Info
Start Date :
January 1 2006
Trial Type :
OBSERVATIONAL
End Date :
January 1 2010
Estimated Enrollment :
350 Patients enrolled
Trial Details
Trial ID
NCT00298844
Start Date
January 1 2006
End Date
January 1 2010
Last Update
March 23 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Odense University Hospital
Odense, Denmark, 5000